Ambrosia Bio Israeli Company

Ambrosia Bio has developed a disruptive enzyme technology platform that is used to design superior enzymes capable of converting obesity-promoting industrial sugars into minimal-calorie rare sugars such as Allulose. Ambrosia Bio’s B2B business model will provide the leading sugar and Food & Beverages (e.g., juice) manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. Ambrosia Bio will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging rare sugars such as Allulose demand.